Stanley P L Leong Selected Research

MM 77

6/2006

Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanley P L Leong Research Topics

Disease

32	Melanoma (Melanoma, Malignant) 01/2017 - 01/2002
20	Neoplasms (Cancer) 02/2015 - 06/2004
15	Neoplasm Metastasis (Metastasis) 05/2014 - 03/2004
9	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2003
3	Disease Progression 05/2014 - 01/2008
2	Lymphatic Metastasis 01/2008 - 09/2006
1	Panniculitis 01/2018
1	Neuroblastoma 05/2012
1	Hypersensitivity (Allergy) 10/2009
1	Nevus (Nevi) 10/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2005
1	Merkel Cell Carcinoma 01/2005
1	Neoplasm Micrometastasis 01/2002

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 02/2015 - 05/2011
5	Indicators and Reagents (Reagents)IBA 10/2012 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 10/2012 - 08/2008
3	Biological ProductsIBA 05/2014 - 05/2011
3	Coloring Agents (Dyes)IBA 02/2013 - 06/2004
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2009 - 01/2002
2	Small Interfering RNA (siRNA)IBA 02/2015 - 05/2012
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 03/2014 - 05/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2009 - 01/2002
1	fetal Alzheimer antigenIBA 02/2015
1	Pharmaceutical PreparationsIBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2014
1	Lactate Dehydrogenase 5IBA 03/2014
1	alpha Subunit Hypoxia-Inducible Factor 1IBA 03/2014
1	VemurafenibIBA 10/2012
1	TensinsIBA 05/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2012
1	Hematoxylin (Haematoxylon)IBA 03/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2012
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 10/2011
1	Technetium (Technetium 99m)IBA 10/2011
1	Mannose ReceptorIBA 04/2011
1	technetium-diethylenetriaminepentaacetic acid-mannosyl-dextranIBA 04/2011
1	Interleukin-4 (Interleukin 4)IBA 10/2009
1	Dactinomycin (Actinomycin)FDA LinkGeneric 10/2009
1	Eukaryotic Initiation Factor-3IBA 10/2008
1	5' Untranslated Regions (5' UTR)IBA 10/2008
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2008
1	OsteopontinIBA 01/2008
1	Nuclear Receptor Coactivator 3IBA 10/2006
1	Genetic Markers (Genetic Marker)IBA 09/2006
1	MM 77IBA 06/2006
1	Colloids (Colloid)IBA 03/2005
1	SulfurIBA 03/2005
1	Interleukin-2 (IL2)IBA 01/2002
1	Interferon-gamma (Interferon, gamma)IBA 01/2002
1	Interleukin-10 (Interleukin 10)IBA 01/2002
1	EnzymesIBA 01/2002
1	CytokinesIBA 01/2002

Therapy/Procedure

19	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 02/2003
10	Therapeutics 01/2018 - 03/2004
2	Immunotherapy 09/2011 - 10/2009
2	Radiotherapy 12/2010 - 01/2009
1	Neoadjuvant Therapy 10/2012
1	Tattooing 11/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Lasers (Laser) 04/2005
1	Metastasectomy 10/2004
1	Adrenalectomy 10/2004